Hennion & Walsh Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-75,787
| Closed | -$380K | – | 844 |
|
|
2024
Q1 | $380K | Buy |
75,787
+5,043
| +7% | +$25.3K | 0.02% | 639 |
|
|
2023
Q4 | $636K | Buy |
70,744
+8,658
| +14% | +$77.8K | 0.04% | 511 |
|
|
2023
Q3 | $482K | Buy |
62,086
+2,465
| +4% | +$19.2K | 0.03% | 529 |
|
|
2023
Q2 | $577K | Sell |
59,621
-99,888
| -63% | -$967K | 0.03% | 475 |
|
|
2023
Q1 | $1.75M | Sell |
159,509
-5,302
| -3% | -$58.1K | 0.11% | 232 |
|
|
2022
Q4 | $712K | Sell |
164,811
-136,874
| -45% | -$591K | 0.04% | 409 |
|
|
2022
Q3 | $2.27M | Buy |
301,685
+3,637
| +1% | +$27.4K | 0.15% | 178 |
|
|
2022
Q2 | $3M | Buy |
298,048
+32,450
| +12% | +$326K | 0.19% | 140 |
|
|
2022
Q1 | $3.29M | Sell |
265,598
-4,407
| -2% | -$54.6K | 0.17% | 158 |
|
|
2021
Q4 | $6.18M | Sell |
270,005
-10,916
| -4% | -$250K | 0.3% | 89 |
|
|
2021
Q3 | $6.22M | Buy |
280,921
+24,378
| +10% | +$540K | 0.33% | 71 |
|
|
2021
Q2 | $3.33M | Buy |
256,543
+82,983
| +48% | +$1.08M | 0.18% | 161 |
|
|
2021
Q1 | $2.25M | Buy |
+173,560
| New | +$2.25M | 0.14% | 208 |
|